Post-discharge GP care cuts heart attack death risk by 13%, study finds

What happens in the year after you leave the hospital following a heart attack may matter more than what happens inside it. Australian researchers examining a decade of linked health records have found that patients who see their GP more frequently in that critical first twelve months face substantially lower odds of dying or being readmitted to hospital. The difference is measurable and significant: each additional GP visit correlates with a 13 percent reduction in death risk and a 6 percent reduction in the chance of returning to hospital for heart-related complications.

The study, conducted across Western Australia between 2010 and 2022, tracked more than 2,000 patients living with both coronary heart disease and type-2 diabetes—a particularly vulnerable group whose mortality rates run nearly double those of people with heart disease alone. Researchers pulled together a complete picture of each patient's healthcare journey by linking data from general practice records, hospital admissions, emergency department visits, and mortality registries. Rather than examining only what occurred during hospital stays, they followed patients backward and forward through the year surrounding their heart attack, watching how they moved between primary and secondary care, what medications they received, and what outcomes they experienced.

The findings underscore a straightforward principle: continuity matters. A GP's role extends beyond prescribing—it encompasses medication review, early detection of deterioration, coordination with specialists, and sustained engagement around lifestyle and risk management. Yet the research also reveals a troubling gap between guideline recommendations and what actually happens in practice. Only about three-quarters of patients received at least one of four medications considered essential for coronary heart disease management. Fewer than one in five received all four. The researchers note this figure may underestimate actual prescribing rates, since hospital-supplied medications given at discharge were not captured in their data, but the disparity still points to inconsistency in how secondary prevention is implemented.

The geographic disparities are stark and demand urgent attention. Patients living in outer regional areas faced a 31 to 35 percent higher risk of readmission compared to those in major cities. Those in remote areas confronted a 57 to 68 percent higher risk of death. For patients with additional complications—heart failure or chronic kidney disease—the risks climbed further, doubling or nearly doubling compared to those with coronary heart disease and diabetes alone. These are not small margins. They represent real people in real places where access to consistent primary care is harder to secure, where coordination between hospital and community providers is more fragmented, and where the infrastructure of follow-up simply does not exist at the same density as in metropolitan centers.

The research points toward specific, actionable changes. Hospitals need to communicate clearly with GPs about each patient's medications, treatment plan, and ongoing needs at the moment of discharge. General practitioners, positioned as the critical leverage point in long-term disease management, should treat post-discharge follow-up as an opportunity to optimize care rather than a routine administrative task. Policymakers and health planners must build integrated care models that are genuinely accessible to people in regional and remote areas and to those managing multiple chronic conditions simultaneously. The goal is not simply more visits, but visits that are timely, coordinated, and of high quality—the kind of continuity that can mean the difference between recovery and crisis in the months after a patient comes home.